Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study-Reference-Cited by-同舟云学术

Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study

Published:2024-03-01 Issue:4 Volume:5 Page:590-600
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

de Blank Peter M. K.^ORCID,Lange Katharine R.^ORCID,Xing Mengqi,Mirzaei Salehabadi Sedigheh,Srivastava Deokumar^ORCID,Brinkman Tara M.,Ness Kirsten K.^ORCID,Oeffinger Kevin C.,Neglia Joseph,Krull Kevin R.^ORCID,Nathan Paul C.^ORCID,Howell Rebecca,Turcotte Lucie M.^ORCID,Leisenring Wendy,Armstrong Gregory T.,Okcu M. Fatih,Bowers Daniel C.^ORCID

Funder

Division of Cancer Prevention, National Cancer Institute

American Lebanese Syrian Associated Charities

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s43018-024-00733-0.pdf

Reference47 articles.

1. Ostrom, Q. T. et al. Alex’s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncol. 16, x1–x36 (2015).

2. Bandopadhayay, P. et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat. Genet. 48, 273–282 (2016).

3. Ryall, S. et al. Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37, 569–583 (2020).

4. Shi, W. et al. Mechanism and protection of radiotherapy induced sensorineural hearing loss for head and neck cancer. BioMed Res. Int. 2021, 3548706 (2021).